Most patients are best served by modern photon-based IMRT/VMAT/SBRT. Proton therapy adds value where reducing normal-tissue dose is critical (paediatric tumours, tumours near critical organs, re-irradiation). Heavy-ion is preferred for selected radioresistant tumours (some sarcomas, recurrent rectal cancers, selected hepatocellular carcinomas).
More on Proton / heavy-ion therapy
Have a follow-up question?
Reply via the quote wizard with case-specific questions and a coordinator will answer in 1–2 business days.